My hero
Best wishes
Paper Tiger
Printable View
Great find Hancocks. Couldn't agree more.
There's a lot of talk about hourly/daily movements in stock price. I'm sure that floats a lot of boats around here. But, as a relatively new Sharetrader contributor and fundie, can we kick off a discussion about what a fair price for PEB is?
I know CEO has talked up $100m earnings in a few years if they can get a chunk of the US market. I assume this is USD? Does PEB have an international currency risk specialist in senior mgmt/Board?
Made an attempt here (very rough): #705
Looking at the P/S and P/E ratios of those estimates would say that those values are too high. However if Cxcolorectal is about to be commercialised in 4-5 years then maybe those numbers are fine? Who knows.
Excellent. Thanks Johnny. I also see that some others had a crack at a price too. Obviously all of your projections are sensitive to your assumed NZ$1=US$0.8. Here's hoping, for PEB's sake, the US sorts itself out, the Fed can stop printing money, and we can get down to $1=$0.60-70!!
Can I ask 2 things based on your s/sheet?
1. What is your IV(Benjamin Graham) calculation? (I'm a little embarrassed to ask as a self-confessed fundie :()
2. Where did you find the Total US Assay Market figure (1825600)? Does the incidence of bladder cancer increase with age? If so, that's probably a conservative figure holding that constant out to 2017. USA has similar demographics to NZ I thought. And obviously, if PEB gets into Spain/Singapore/Aus etc then this figure is even more conservative!
Just another back of the envelope rough calculation of value. Check out http://en.wikipedia.org/wiki/Benjamin_Graham_formula. I got the market figures from something released by PEB (can't quite remember where).
I'm by no means a chartist, but based on history it looks like PEB is getting close to going on another big run (assuming history repeats, of course). What are people's thoughts?
Attachment 4431
Saw this on a media alert this morning...is this new/old news (sorry but busy day and no time to trawl through the thread)...
Brent Pownall has joined Pacific Edge Diagnostics NZ in Dunedin and will lead the commercial activity of Pacific Edge’s innovative and non-invasive bladder cancer diagnostic system Cxbladder in New Zealand and Australia. Pownall was formerly with MP Biomedicals as New Zealand sales director and country manager.
Originally published 4 March 2013
http://www.pacificedge.co.nz/news/article/40